Re: Amar U. Kishan, Luca F. Valle, Holly Wilhalme, et al. 177Lu-Prostate-specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-label, Randomized, Controlled, Phase II Study. J Clin Oncol 2025;43:3812–21

European Urology Open Science 2026 Open access

Read full text

Authors: Vérane Achard, Thomas Zilli, Bertrand Tombal

DOI: 10.1016/j.euros.2026.01.001

Cited by: 1

References: 6

Fields of Study & Subjects

Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Radiopharmaceutical Chemistry and Applications

References 6